<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - B. Pharm VIII Sem. Syllabus</title><meta name="author" content="AcademicsOne"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 13pt; }
 h3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; margin:0pt; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; vertical-align: 4pt; }
 .s3 { color: black; font-family:Calibri, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 h4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11pt; }
 .s4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 .s5 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 12pt; }
 a { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 14pt; }
 .s6 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .s7 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s8 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s9 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .s10 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 .s11 { color: #101010; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l1 {padding-left: 0pt; }
 #l1> li>*:first-child:before {content: "• "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l2 {padding-left: 0pt;counter-reset: d1 1; }
 #l2> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt; }
 #l3> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l4 {padding-left: 0pt;counter-reset: f1 1; }
 #l4> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: g1 1; }
 #l5> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: h1 1; }
 #l6> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 #l7 {padding-left: 0pt;counter-reset: h2 1; }
 #l7> li>*:first-child:before {counter-increment: h2; content: counter(h2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: h2 0;  }
 li {display: block; }
 #l8 {padding-left: 0pt;counter-reset: i1 1; }
 #l8> li>*:first-child:before {counter-increment: i1; content: counter(i1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: i1 0;  }
 #l9 {padding-left: 0pt;counter-reset: i2 1; }
 #l9> li>*:first-child:before {counter-increment: i2; content: counter(i2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: i2 0;  }
 #l10 {padding-left: 0pt; }
 #l10> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; }
 li {display: block; }
 #l11 {padding-left: 0pt;counter-reset: j1 1; }
 #l11> li>*:first-child:before {counter-increment: j1; content: counter(j1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l11> li:first-child>*:first-child:before {counter-increment: j1 0;  }
 li {display: block; }
 #l12 {padding-left: 0pt;counter-reset: k1 1; }
 #l12> li>*:first-child:before {counter-increment: k1; content: counter(k1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l12> li:first-child>*:first-child:before {counter-increment: k1 0;  }
 li {display: block; }
 #l13 {padding-left: 0pt;counter-reset: l1 1; }
 #l13> li>*:first-child:before {counter-increment: l1; content: counter(l1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l13> li:first-child>*:first-child:before {counter-increment: l1 0;  }
 #l14 {padding-left: 0pt; }
 #l14> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l15 {padding-left: 0pt;counter-reset: m1 1; }
 #l15> li>*:first-child:before {counter-increment: m1; content: counter(m1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l15> li:first-child>*:first-child:before {counter-increment: m1 0;  }
 #l16 {padding-left: 0pt; }
 #l16> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; }
 li {display: block; }
 #l17 {padding-left: 0pt;counter-reset: n1 1; }
 #l17> li>*:first-child:before {counter-increment: n1; content: counter(n1, lower-latin)") "; color: #202020; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l17> li:first-child>*:first-child:before {counter-increment: n1 0;  }
 li {display: block; }
 #l18 {padding-left: 0pt;counter-reset: o1 1; }
 #l18> li>*:first-child:before {counter-increment: o1; content: counter(o1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l18> li:first-child>*:first-child:before {counter-increment: o1 0;  }
 li {display: block; }
 #l19 {padding-left: 0pt;counter-reset: p1 1; }
 #l19> li>*:first-child:before {counter-increment: p1; content: counter(p1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l19> li:first-child>*:first-child:before {counter-increment: p1 0;  }
 li {display: block; }
 #l20 {padding-left: 0pt;counter-reset: q1 1; }
 #l20> li>*:first-child:before {counter-increment: q1; content: counter(q1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l20> li:first-child>*:first-child:before {counter-increment: q1 0;  }
 li {display: block; }
 #l21 {padding-left: 0pt;counter-reset: r1 1; }
 #l21> li>*:first-child:before {counter-increment: r1; content: counter(r1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l21> li:first-child>*:first-child:before {counter-increment: r1 0;  }
 li {display: block; }
 #l22 {padding-left: 0pt;counter-reset: s1 1; }
 #l22> li>*:first-child:before {counter-increment: s1; content: counter(s1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l22> li:first-child>*:first-child:before {counter-increment: s1 0;  }
 li {display: block; }
 #l23 {padding-left: 0pt;counter-reset: t1 1; }
 #l23> li>*:first-child:before {counter-increment: t1; content: counter(t1, decimal)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l23> li:first-child>*:first-child:before {counter-increment: t1 0;  }
 #l24 {padding-left: 0pt; }
 #l24> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l25 {padding-left: 0pt;counter-reset: u1 1; }
 #l25> li>*:first-child:before {counter-increment: u1; content: counter(u1, lower-latin)". "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l25> li:first-child>*:first-child:before {counter-increment: u1 0;  }
 li {display: block; }
 #l26 {padding-left: 0pt;counter-reset: v1 1; }
 #l26> li>*:first-child:before {counter-increment: v1; content: counter(v1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l26> li:first-child>*:first-child:before {counter-increment: v1 0;  }
 #l27 {padding-left: 0pt; }
 #l27> li>*:first-child:before {content: " "; color: black; font-family:Symbol, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 li {display: block; }
 #l28 {padding-left: 0pt;counter-reset: w1 10; }
 #l28> li>*:first-child:before {counter-increment: w1; content: counter(w1, upper-roman)"- "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11pt; }
 #l28> li:first-child>*:first-child:before {counter-increment: w1 0;  }
 #l29 {padding-left: 0pt;counter-reset: w2 1; }
 #l29> li>*:first-child:before {counter-increment: w2; content: counter(w2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l29> li:first-child>*:first-child:before {counter-increment: w2 0;  }
 li {display: block; }
 #l30 {padding-left: 0pt;counter-reset: x1 1; }
 #l30> li>*:first-child:before {counter-increment: x1; content: counter(x1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l30> li:first-child>*:first-child:before {counter-increment: x1 0;  }
 #l31 {padding-left: 0pt;counter-reset: x2 1; }
 #l31> li>*:first-child:before {counter-increment: x2; content: counter(x2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l31> li:first-child>*:first-child:before {counter-increment: x2 0;  }
 li {display: block; }
 #l32 {padding-left: 0pt;counter-reset: y1 1; }
 #l32> li>*:first-child:before {counter-increment: y1; content: counter(y1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; }
 #l32> li:first-child>*:first-child:before {counter-increment: y1 0;  }
 li {display: block; }
 #l33 {padding-left: 0pt;counter-reset: z1 1; }
 #l33> li>*:first-child:before {counter-increment: z1; content: counter(z1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l33> li:first-child>*:first-child:before {counter-increment: z1 0;  }
 li {display: block; }
 #l34 {padding-left: 0pt;counter-reset: c1 1; }
 #l34> li>*:first-child:before {counter-increment: c1; content: counter(c1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l34> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 li {display: block; }
 #l35 {padding-left: 0pt;counter-reset: d1 1; }
 #l35> li>*:first-child:before {counter-increment: d1; content: counter(d1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l35> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l36 {padding-left: 0pt;counter-reset: d2 1; }
 #l36> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l36> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 #l37 {padding-left: 0pt;counter-reset: d3 1; }
 #l37> li>*:first-child:before {counter-increment: d3; content: counter(d3, lower-roman)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l37> li:first-child>*:first-child:before {counter-increment: d3 0;  }
 li {display: block; }
 #l38 {padding-left: 0pt;counter-reset: e1 1; }
 #l38> li>*:first-child:before {counter-increment: e1; content: counter(e1, lower-roman)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l38> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 table, tbody {vertical-align: top; overflow: visible; }
</style><link rel="sitemap" type="application/xml" title="Sitemap" href="/sitemap.xml"></head><body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download</button></a></div><script>const a=(window.location.pathname).split(/);const filename=a[a.length-1].replace(".html",".pdf").replace(".htm",".pdf");document.getElementById("pdf-download-link").href=filename;</script><h2 style="padding-top: 3pt;padding-left: 25pt;text-indent: 0pt;text-align: center;">SEMESTERVIII</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 49pt;text-indent: 0pt;text-align: left;">BP801T.BIOSTATISITCSANDRESEARCHMETHODOLOGY(Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 396pt;text-indent: 0pt;text-align: left;">45Hours</h3><h3 style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Scope: <span class="p">To understand the applications of Biostatics in Pharmacy. This subject deals withdescriptive   statistics,Graphics,   Correlation,Regression,   logistic  regression Probabilitytheory,Samplingtechnique,Parametrictests,NonParametrictests,ANOVA,Introd uction  to  Design  of  Experiments,  Phases  of  Clinical  trials  and  Observational andExperimentalstudies,SPSS,RandMINITABstatisticalsoftware’s,analyzingthestatistical datausingExcel</span>.</h3><h3 style="padding-top: 9pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthecoursethestudentshallbeableto</span></h3><ul id="l1"><li data-list-text="•"><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;line-height: 114%;text-align: left;">KnowtheoperationofM.S.Excel,SPSS,RandMINITAB<span class="s1">®</span>, DoE(DesignofExperiment)</p></li><li data-list-text="•"><p style="padding-left: 44pt;text-indent: -7pt;text-align: left;">Knowthevariousstatisticaltechniquestosolvestatisticalproblems</p></li><li data-list-text="•"><p style="padding-top: 1pt;padding-left: 44pt;text-indent: -7pt;text-align: left;">Appreciatestatisticaltechniquesinsolvingtheproblems<b>.</b></p></li></ul><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 221pt;text-indent: 0pt;text-align: left;">Coursecontent:</h3><h3 style="padding-top: 6pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-I                                      10Hours</h3><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Introduction:<span class="p">Statistics,Biostatistics,Frequencydistribution</span></h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Measures  of  central  tendency<span class="p">:Mean,  Median,  Mode-  Pharmaceutical examples</span>Measures   of   dispersion<span class="p">:   Dispersion,   Range,   standard deviation,Pharmaceuticalproblems</span></h3><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: justify;">Correlation<span class="p">: Definition, Karl Pearson’s coefficient of correlation, Multiple correlation - Pharmaceuticalsexamples</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-II                                      10Hours</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Regression: <span class="p">Curve fittingbythe methodof leastsquares, fittingthelines y=a+bxandx</span></h3><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">=a+by,Multipleregression,standarderrorofregression– PharmaceuticalExamples<b>Probability:</b>Definition of probability, Binomial distribution, Normal distribution,Poisson’sdistribution,properties -problems Sample,Population,largesample,smallsample, Nullhypothesis,alternativehypothesis,sampling, essence of sampling, types of sampling, Error-I type,Error-II type, Standarderrorofmean(SEM)-Pharmaceutical examples <b>Parametric test</b>: t-test(Sample, Pooled or Unpaired and Paired) , ANOVA, (One wayandTwoway),Least Significancedifference</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Unit-III                                      10Hours</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Non Parametric tests: <span class="p">Wilcoxon Rank Sum Test, Mann-Whitney U test, Kruskal- Wallistest,FriedmanTest</span></h3><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Introduction to Research: <span class="p">Need for research, Need for design of Experiments,ExperientialDesign Technique,plagiarism</span></h3><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Graphs: <span class="p">Histogram, Pie Chart, Cubic Graph, response surface plot, Counter Plot graph</span>Designingthemethodology:<span class="p">SamplesizedeterminationandPowerofastudy,Reportw ritingandpresentationofdata,Protocol,Cohorts    studies, Observational studies,Experimental studies,Designingclinical trial,various phases.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-IV                                      8Hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Blockingandconfoundingsystem forTwo-level factorials</p><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: left;"><b>Regression modeling: </b>Hypothesis testing in Simple and Multiple regressionmodels<b>IntroductiontoPracticalcomponentsofIndustrialandClinicalTrialsPr oblems</b>:StatisticalAnalysisUsingExcel,SPSS,MINITAB<span class="s1">®</span>,DESIGNOFEXPERIMENTS,R- OnlineStatisticalSoftware’stoIndustrialandClinical trialapproach</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit-V                                      7Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Design andAnalysisofexperiments:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 12pt;line-height: 112%;text-align: left;"><b>Factorial Design: </b>Definition, 2<span class="s1">2</span>, 2<span class="s1">3</span>design. Advantage of factorial design<b>ResponseSurfacemethodology</b>:Centralcompositedesign,Historicaldesign, OptimizationTechniques</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RecommendedBooks(Latestedition):</h3><ol id="l2"><li data-list-text="1."><p style="padding-top: 11pt;padding-left: 64pt;text-indent: -18pt;line-height: 114%;text-align: left;">Pharmaceuticalstatistics- Practicalandclinicalapplications,SanfordBolton,publisherMarcel DekkerInc.NewYork.</p></li><li data-list-text="2."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;">FundamentalofStatistics –HimalayaPublishingHouse-S.C.Guptha</p></li><li data-list-text="3."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">DesignandAnalysisofExperiments–PHI     LearningPrivateLimited,</p><p style="padding-top: 2pt;padding-left: 302pt;text-indent: 0pt;text-align: left;">R.Pannerselvam,</p></li><li data-list-text="4."><p style="padding-top: 2pt;padding-left: 118pt;text-indent: -72pt;line-height: 111%;text-align: left;">Design and AnalysisofExperiments– WileyStudentsEdition,DouglasandC.Montgomery</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 10pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Scope:</h3><p style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">BP802TSOCIALAND PREVENTIVEPHARMACY <b>(Theory)</b></p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Hours:45</h3><p style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">The purpose of this course is to introduce to students a number of health issues and theirchallenges. This course also introduced a number of national health programmes. Therolesofthe pharmacistinthesecontextsarealso discussed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Objectives:</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Afterthesuccessfulcompletionofthiscourse,thestudentshallbeableto:</p><ul id="l3"><li data-list-text=""><p style="padding-left: 64pt;text-indent: -18pt;text-align: left;">Acquirehighconsciousness/realizationofcurrentissuesrelatedtohealthandpharmace uticalproblemswithinthe countryandworldwide.</p></li><li data-list-text=""><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;">Have a critical wayofthinkingbasedon current healthcaredevelopment.</p></li><li data-list-text=""><p style="padding-left: 118pt;text-indent: -72pt;text-align: left;">Evaluate  alternative  ways  of  solving  problems  related  tohealth andpharmaceuticalissues</p></li></ul><h3 style="padding-left: 204pt;text-indent: 0pt;text-align: left;">Coursecontent:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">UnitI:                                      10Hours</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Concept of health and disease: <span class="p">Definition, concepts and evaluation of public health.Understanding the concept of prevention and control of disease, social causes of diseasesandsocial problems of thesick.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Social and health education: <span class="p">Food in relation to nutrition and health, Balanced diet,Nutritionaldeficiencies,Vitamindeficiencies,Malnutrition anditsprevention.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Sociology and health: <span class="p">Socio cultural factors related to health and disease, Impact ofurbanization onhealth anddisease, Povertyand health</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Hygieneandhealth:<span class="p">personalhygieneandhealthcare; avoidablehabits</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">UnitII:                                     10Hours</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Preventive medicine: <span class="p">General principles of prevention and control of diseases such ascholera,SARS,Ebolavirus,influenza,acuterespiratory infections,malaria,chickenguinea, dengue,  lymphatic  filariasis,  pneumonia,  hypertension,  diabetes  mellitus, cancer,drugaddiction-drugsubstanceabuse</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIII:                                     10Hours</h3><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: left;">National health  programs,  its objectives,  functioning and  outcome of the following:<span class="p">HIVANDAIDScontrolprogramme,TB,Integrateddiseasesurveillanceprogram(I DSP),Nationalleprosycontrolprogramme,Nationalmentalhealthprogram,National</span></h3><p style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">programme  for  prevention  and  control  of  deafness,  Universal  immunization programme,Nationalprogrammeforcontrolofblindness,Pulsepolioprogramme.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">UnitIV:                                     08Hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">National  health  intervention programme  for  mother  and  child,  National  family welfareprogramme, National tobacco control programme, National Malaria Prevention Program,National programme for the health care for the elderly, Social health programme; role ofWHOinIndian nationalprogram</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">UnitV:                                     07Hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Community services in rural, urban and school health: Functions of PHC,Improvementin rural sanitation, national urban health mission, Health promotion and education inschool.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RecommendedBooks(Latestedition)<i>:</i></h3><ol id="l4"><li data-list-text="1."><p style="padding-top: 11pt;padding-left: 55pt;text-indent: -18pt;line-height: 114%;text-align: justify;">Short  Textbook of Preventive  and  Social  Medicine,  Prabhakara  GN,  2<span class="s1">nd</span> Edition,2010,ISBN: 9789380704104, JAYPEEPublications</p></li><li data-list-text="2."><p style="padding-left: 55pt;text-indent: -18pt;line-height: 112%;text-align: justify;">	Textbook of Preventive and Social Medicine (Mahajan and Gupta), Edited by RoyRabindra  Nath,  Saha  Indranil,  4<span class="s1">th</span>Edition,  2013,  ISBN:  9789350901878, JAYPEEPublications</p></li><li data-list-text="3."><p style="padding-top: 1pt;padding-left: 55pt;text-indent: -18pt;line-height: 108%;text-align: left;">Review of Preventive and Social Medicine (Including Biostatistics), Jain Vivek, 6<span class="s1">th</span>Edition,2014,ISBN: 9789351522331, JAYPEEPublications</p></li><li data-list-text="4."><p style="padding-top: 1pt;padding-left: 56pt;text-indent: -18pt;text-align: left;">EssentialsofCommunity                           Medicine—</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">APracticalApproach,HiremathLalitaD,HiremathDhananjayaA,2<span class="s1">nd</span>Edition,2012,ISBN</p><p style="padding-top: 1pt;padding-left: 55pt;text-indent: 0pt;text-align: left;">:9789350250440,JAYPEEPublications</p></li><li data-list-text="5."><p style="padding-top: 3pt;padding-left: 55pt;text-indent: -18pt;line-height: 111%;text-align: left;">	ParkTextbook   ofPreventiveandSocialMedicine,KPark,21<span class="s1">st</span>Edition,2011,ISBN- 14:9788190128285,BANARSIDASBHANOTPUBLISHERS.</p></li><li data-list-text="6."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">CommunityPharmacyPractice,RameshAdepu,BSPpublishers, Hyderabad</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Journals:</h3><ol id="l5"><li data-list-text="1."><p style="padding-top: 11pt;padding-left: 46pt;text-indent: -9pt;text-align: left;">ResearchinSocialandAdministrativePharmacy,Elsevier,Ireland</p></li></ol><h3 style="padding-top: 3pt;padding-left: 31pt;text-indent: 0pt;text-align: center;">BP803ET. Pharmaceutical Marketing Management (Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 413pt;text-indent: 0pt;text-align: left;">45Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Scope:</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">The pharmaceutical industry not only needs highly qualified researchers, chemists and,technicalpeople, butalsorequires skilled managers who cantake the industry forwardby managing and taking the complex decisions which are imperative for the growth of theindustry.  The  KnowledgeandKnow-how  ofmarketing  managementgroomthe peoplefortakingachallenging rolein Sales and Productmanagement.</p><h3 style="padding-top: 9pt;padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: justify;">Course Objective: <span class="p">The course aims to provide an understanding of marketing conceptsandtechniques andtheirapplicationsinthepharmaceuticalindustry.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitI                                      10Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Marketing:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Definition, general concepts and scope of marketing; Distinction between marketing &amp;selling;  Marketing  environment;  Industry  and  competitive  analysis;  Analyzing consumerbuyingbehavior; industrial buyingbehavior.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Pharmaceuticalmarket:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Quantitative  and  qualitative  aspects;  size  and  composition  of  the  market; demographicdescriptionsandsocio- psychologicalcharacteristicsoftheconsumer;marketsegmentation&amp;targeting.Consumerprofi le;Motivationandprescribinghabitsofthephysician;patients&#39;  choice  of  physicianand retailpharmacist.Analyzing the Market;Roleofmarket research.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitII                                  10Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Productdecision:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Classification,   product   line   and   product   mix   decisions,   product lifecycle,productportfolioanalysis;productpositioning;New productdecisions;Productbranding,packagingandlabelingdecisions,Productmanagementinp harmaceuticalindustry.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIII                                     10Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Promotion:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Methods,determinantsofpromotionalmix,promotionalbudget;Anoverviewofpersonalselling</p><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">,advertising,directmail,journals,sampling,retailing, medicalexhibition,publicrelations,onlinepromotionaltechniques forOTCProducts.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 26pt;text-indent: 0pt;text-align: center;">160</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIV                                     10Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: left;">Pharmaceuticalmarketingchannels: <span class="p">Designingchannel,channelmembers,selectingtheappropriatechannel,conflictinchannels,phy sicaldistributionmanagement:Strategicimportance,tasksinphysicaldistributionmanagement.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 111%;text-align: left;">Professionalsalesrepresentative(PSR): <span class="p">DutiesofPSR,purposeofdetailing,selectionandtraining,supervising,normsforcustomercalls, motivating,evaluating,compensationandfutureprospectsofthePSR.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitV                                      10Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Pricing:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Meaning,  importance,  objectives,  determinants  of  price;  pricing  methods  and strategies,issuesinpricemanagementinpharmaceuticalindustry.AnoverviewofDPCO(DrugP riceControlOrder)andNPPA(NationalPharmaceuticalPricingAuthority).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Emergingconceptsinmarketing:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Vertical  &amp;  Horizontal  Marketing;  RuralMarketing;  Consumerism;  Industrial Marketing;GlobalMarketing.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books:(LatestEditions)</h3><ol id="l6"><li data-list-text="1."><p style="padding-top: 1pt;padding-left: 41pt;text-indent: -13pt;line-height: 112%;text-align: left;">	PhilipKotlerandKevinLaneKeller:MarketingManagement,PrenticeHallofIndia,NewDel hi</p></li><li data-list-text="2."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 117%;text-align: left;">Walker,BoydandLarreche:MarketingStrategy-PlanningandImplementation,TataMC GrawHill,NewDelhi.</p></li><li data-list-text="3."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 14pt;text-align: left;">DhruvGrewalandMichaelLevy:Marketing,TataMCGrawHill</p></li><li data-list-text="4."><p style="padding-top: 1pt;padding-left: 41pt;text-indent: -13pt;text-align: left;">ArunKumarandNMenakshi:MarketingManagement,VikasPublishing,India</p></li><li data-list-text="5."><p style="padding-top: 2pt;padding-left: 41pt;text-indent: -13pt;text-align: left;">RajanSaxena:MarketingManagement; TataMC Graw-Hill(IndiaEdition)</p></li><li data-list-text="6."><p style="padding-top: 1pt;padding-left: 41pt;text-indent: -13pt;line-height: 114%;text-align: left;">	Ramaswamy,U.S&amp;Nanakamari,S:MarketingManagemnt:GlobalPerspective,IndianCon text,MacmilanIndia,NewDelhi.</p></li><li data-list-text="7."><p style="padding-left: 41pt;text-indent: -13pt;text-align: left;">Shanker,Ravi:ServiceMarketing,ExcellBooks,NewDelhi</p></li><li data-list-text="8."><p style="padding-top: 2pt;padding-left: 41pt;text-indent: -13pt;line-height: 118%;text-align: left;">SubbaRaoChanganti,PharmaceuticalMarketinginIndia(GIFT– Excelseries)ExcelPublications.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 5pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">161</p><h3 style="padding-top: 3pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">BP804ET:PHARMACEUTICALREGULATORYSCIENCE(Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="text-indent: 0pt;text-align: right;">45Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 9pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Scope:  <span class="p">This  course  is  designed  to  impart  the  fundamental  knowledge  on  the regulatoryrequirementsforapprovalofnewdrugs,     anddrugproductsinregulatedmarkets ofIndia    &amp;    other    countries    like    US,    EU,Japan,Australia,UK etc.Itpreparesthestudentstolearnindetailonthe regulatoryrequirements,documentationrequirements,andregistrationprocedures formarketingthedrugproducts.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthesubjectstudentshallbeableto;</span></h3><ol id="l7"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 66pt;text-indent: -20pt;text-align: left;">Know about the processof drugdiscoveryanddevelopment</p></li><li data-list-text="2."><p style="padding-top: 6pt;padding-left: 64pt;text-indent: -18pt;text-align: left;">Knowtheregulatoryauthoritiesandagenciesgoverningthemanufactureandsaleofpha rmaceuticals</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 64pt;text-indent: -18pt;text-align: left;">KnowtheregulatoryapprovalprocessandtheirregistrationinIndianandintern ationalmarkets</p></li></ol></li></ol><h3 style="padding-top: 7pt;padding-left: 31pt;text-indent: 0pt;text-align: center;">Coursecontent:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitI                                         10Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">NewDrugDiscoveryanddevelopment</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Stages of drug discovery, Drug development  process, pre-clinical studies,  non- clinicalactivities, clinical studies,Innovator andgenerics, Concept of generics, Generic drugproductdevelopment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">UnitII                                        10Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RegulatoryApprovalProcess</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: -1pt;text-align: justify;">Approvalprocessesandtimelines involved inInvestigationalNew Drug (IND),NewDrug Application  (NDA),  Abbreviated  New  Drug  Application  (ANDA).  Changes  to anapprovedNDA/ ANDA.</p><h3 style="padding-top: 6pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Regulatoryauthorities andagencies</h3><p style="padding-top: 6pt;padding-left: 28pt;text-indent: -1pt;text-align: left;">Overview  of  regulatory  authorities  of  India,  United  States,  European Union,Australia,Japan,Canada(Organizationstructureand typesofapplications)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">UnitIII                                        10Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RegistrationofIndiandrugproductinoverseas market</h3><p style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Procedure for export of pharmaceutical products, Technical documentation, Drug MasterFiles(DMF),CommonTechnicalDocument(CTD),electronicCommonTechnical</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 5pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">162</p><p style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Document(eCTD),ASEANCommonTechnicalDocument(ACTD)research.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIV                                        08Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Clinicaltrials</h3><p style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Developingclinicaltrialprotocols,InstitutionalReviewBoard/IndependentEthicscommittee- formationandworkingprocedures,Informedconsentprocessandprocedures,GCPobligationso fInvestigators,sponsors&amp;Monitors,Managing            andMonitoringclinical trials,Pharmacovigilance-safetymonitoringinclinical trials</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitV                                         07Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 27pt;text-indent: 0pt;text-align: left;">RegulatoryConcepts</h3><p style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Basicterminology,guidance,guidelines,regulations,LawsandActs,Orangebook,FederalReg ister,CodeofFederalRegulatory, Purplebook</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">Recommended books(Latestedition):</h3><ol id="l8"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 55pt;text-indent: -17pt;text-align: justify;">DrugRegulatoryAffairsbySachinItkar,Dr.N.S.Vyawahare,Nirali Prakashan.</p></li><li data-list-text="2."><p style="padding-left: 55pt;text-indent: -18pt;text-align: justify;">	The Pharmaceutical Regulatory Process, Second Edition Edited by Ira R. Berry andRobertP. Martin, Drugs and the Pharmaceutical Sciences,Vol.185. Informa HealthcarePublishers.</p></li><li data-list-text="3."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">NewDrugApprovalProcess:AcceleratingGlobalRegistrationsByRichardAGuar ino,MD,5<span class="s1">th</span>edition,DrugsandthePharmaceuticalSciences,Vol.190.</p></li><li data-list-text="4."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">Guidebookfordrugregulatorysubmissions/SandyWeinberg.ByJohnWiley&amp;Sons.I nc.</p></li><li data-list-text="5."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">FDARegulatoryAffairs:aguideforprescriptiondrugs,medicaldevices,andbiolo gics/edited byDouglas J. Pisano,David Mantus.</p></li><li data-list-text="6."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">GenericDrugProductDevelopment,SolidOralDosageforms,LeonShargelandIsader Kaufer,Marcel Dekkerseries,Vol.143</p></li><li data-list-text="7."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">ClinicalTrialsandHumanResearch:APracticalGuidetoRegulatoryComplianceByFay A.RozovskyandRodneyK.Adams</p></li><li data-list-text="8."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">PrinciplesandPracticesof ClinicalResearch, SecondEditionEditedby JohnI.GallinandFrederick P.Ognibene</p></li><li data-list-text="9."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">Drugs:FromDiscoveryto Approval,SecondEditionByRickNg</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 5pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">163</p><h3 style="padding-top: 3pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">BP805T:PHARMACOVIGILANCE(Theory)</h3><h4 style="padding-top: 2pt;text-indent: 0pt;text-align: right;">45hours</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Scope: <span class="s4">This paper will provide an opportunity for the student to learn about development ofpharmacovigilanceasa   science,   basic   terminologies   used   inpharmacovigilance, globalscenarioofPharmacovigilance,trainstudentsonestablishingpharmacovigilanceprogrammeinan organization, various methods that can be used to generate safety data and signal detection. Thispaperalsodevelopstheskillsof classifyingdrugs,diseasesandadversedrugreactions.</span></h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives:</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s5" style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: justify;">At completion of this paper it is expected that students will be able to (know, do, andappreciate):</p><ol id="l9"><li data-list-text="1."><p class="s4" style="padding-top: 10pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Whydrugsafetymonitoringisimportant?</p></li><li data-list-text="2."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Historyanddevelopmentofpharmacovigilance</p></li><li data-list-text="3."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Nationalandinternationalscenarioofpharmacovigilance</p></li><li data-list-text="4."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Dictionaries,codingandterminologiesusedinpharmacovigilance</p></li><li data-list-text="5."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Detectionofnewadversedrugreactionsandtheirassessment</p></li><li data-list-text="6."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;text-align: left;">Internationalstandardsforclassificationofdiseasesanddrugs</p></li><li data-list-text="7."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Adversedrugreactionreportingsystemsandcommunicationinpharmacovigilance</p></li><li data-list-text="8."><p class="s4" style="padding-left: 64pt;text-indent: -18pt;text-align: left;">Methodstogeneratesafetydataduringpreclinical,clinicalandpostapprovalphasesofdrugs’ life cycle</p></li><li data-list-text="9."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Drugsafetyevaluationinpaediatrics,geriatrics,pregnancyandlactation</p></li><li data-list-text="10."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">PharmacovigilanceProgramofIndia(PvPI)requirement for ADRreportinginIndia</p></li><li data-list-text="11."><p class="s4" style="padding-left: 64pt;text-indent: -18pt;line-height: 13pt;text-align: left;">ICHguidelinesforICSR,PSUR,expeditedreporting,pharmacovigilanceplanning</p></li><li data-list-text="12."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">CIOMSrequirementsforADRreporting</p></li><li data-list-text="13."><p class="s4" style="padding-left: 63pt;text-indent: -17pt;text-align: left;">Writingcasenarrativesofadverseeventsandtheirquality.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 25pt;text-indent: 0pt;text-align: center;">CourseContent</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitI                                            10Hours</h4><h4 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">IntroductiontoPharmacovigilance</h4><ul id="l10"><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">HistoryanddevelopmentofPharmacovigilance</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 82pt;text-indent: -18pt;text-align: left;">ImportanceofsafetymonitoringofMedicine</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">WHOinternationaldrugmonitoringprogramme</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">PharmacovigilanceProgramofIndia(PvPI)</p><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Introductiontoadversedrugreactions</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">DefinitionsandclassificationofADRs</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Detectionandreporting</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">MethodsinCausalityassessment</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Severityandseriousnessassessment</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Predictabilityandpreventabilityassessment</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Managementofadversedrugreactions</p><h4 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Basicterminologiesusedinpharmacovigilance</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 5pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">164</p></li><li data-list-text=""><p class="s4" style="padding-top: 4pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Terminologiesofadversemedicationrelatedevents</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Regulatoryterminologies</p><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit II                                           10hours</h4><h4 style="padding-top: 2pt;padding-left: 33pt;text-indent: 0pt;text-align: left;">Druganddiseaseclassification</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Anatomical,therapeuticandchemicalclassificationofdrugs</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 82pt;text-indent: -18pt;text-align: left;">Internationalclassificationofdiseases</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Dailydefineddoses</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 82pt;text-indent: -18pt;text-align: left;">InternationalNonproprietaryNamesfordrugs</p><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Drugdictionariesandcodinginpharmacovigilance</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">WHOadversereactionterminologies</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">MedDRAandStandardisedMedDRAqueries</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">WHOdrugdictionary</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Eudravigilancemedicinalproductdictionary</p><h4 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Informationresourcesinpharmacovigilance</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Basicdruginformationresources</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">SpecialisedresourcesforADRs</p><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Establishingpharmacovigilanceprogramme</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Establishinginahospital</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Establishment &amp;operationofdrugsafetydepartment inindustry</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">ContractResearchOrganisations(CROs)</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Establishinganationalprogramme</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Unit III                                          10Hours</h4><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Vaccinesafetysurveillance</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">VaccinePharmacovigilance</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Vaccinationfailure</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Adverseeventsfollowingimmunization</p><h4 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Pharmacovigilancemethods</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Passivesurveillance–Spontaneousreportsandcaseseries</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Stimulatedreporting</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Activesurveillance–Sentinelsites,drugeventmonitoringandregistries</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 82pt;text-indent: -18pt;text-align: left;">Comparativeobservationalstudies– Crosssectionalstudy,casecontrolstudyandcohort study</p></li><li data-list-text=""><p class="s4" style="padding-top: 2pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Targetedclinicalinvestigations</p><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Communicationinpharmacovigilance</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">EffectivecommunicationinPharmacovigilance</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">CommunicationinDrugSafetyCrisismanagement</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 82pt;text-indent: -18pt;line-height: 112%;text-align: left;">CommunicatingwithRegulatoryAgencies,BusinessPartners,Healthcarefacilities&amp;Me dia</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 11pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">165</p><h4 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIV                                           8Hours</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Safetydatageneration</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Preclinicalphase</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Clinicalphase</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Postapprovalphase(PMS)</p><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">ICHGuidelinesforPharmacovigilance</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">OrganizationandobjectivesofICH</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Expeditedreporting</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 82pt;text-indent: -18pt;text-align: left;">Individualcasesafetyreports</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Periodicsafetyupdatereports</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Postapprovalexpeditedreporting</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Pharmacovigilanceplanning</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Goodclinicalpracticeinpharmacovigilancestudies</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitV                                        7hours</h4><h4 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Pharmacogenomicsofadversedrugreactions</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 78pt;text-indent: -15pt;text-align: left;">GeneticsrelatedADRwithexamplefocusingPKparameters.</p><h4 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Drugsafetyevaluationinspecialpopulation</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Paediatrics</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Pregnancyandlactation</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Geriatrics</p><h4 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">CIOMS</h4></li><li data-list-text=""><p class="s4" style="padding-left: 81pt;text-indent: -17pt;text-align: left;">CIOMSWorkingGroups</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">CIOMSForm</p><h4 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">CDSCO(India)andPharmacovigilance</h4></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">D&amp;CActandScheduleY</p></li><li data-list-text=""><p class="s4" style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">DifferencesinIndianandglobalpharmacovigilancerequirements</p></li></ul></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RecommendedBooks(Latestedition):</h3><ol id="l11"><li data-list-text="1."><p style="padding-left: 63pt;text-indent: -17pt;text-align: left;">TextbookofPharmacovigilance:SKGupta,JaypeeBrothers,Medical Publishers.</p></li><li data-list-text="2."><p style="padding-left: 64pt;text-indent: -18pt;text-align: left;">PracticalDrugSafetyfromAtoZByBartonCobert,PierreBiron,JonesandBartlettPubli shers.</p></li><li data-list-text="3."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;">Mann&#39;sPharmacovigilance:ElizabethB.Andrews,Nicholas,WileyPublishers.</p></li><li data-list-text="4."><p style="padding-left: 64pt;text-indent: -18pt;text-align: left;">Stephens&#39;DetectionofNewAdverseDrug Reactions:JohnTalbot,PatrickWalle,WileyPublishers.</p></li><li data-list-text="5."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;">AnIntroductiontoPharmacovigilance:PatrickWaller,WileyPublishers.</p></li><li data-list-text="6."><p style="padding-left: 64pt;text-indent: -18pt;text-align: left;">Cobert&#39;sManualofDrugSafetyandPharmacovigilance:BartonCobert,Jones&amp;Bartlett Publishers.</p></li><li data-list-text="7."><p style="padding-left: 64pt;text-indent: -18pt;text-align: left;">TextbookofPharmacoepidemiologeditedbyBrianL.Strom,StephenEKimmel,SeanH ennessy,WileyPublishers.</p></li><li data-list-text="8."><p style="padding-left: 64pt;text-indent: -18pt;text-align: left;">ATextbookofClinicalPharmacyPractice- EssentialConceptsandSkills:G.Parthasarathi,Karin NyfortHansen,MilapC.Nahata</p></li><li data-list-text="9."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;">NationalFormularyofIndia</p></li><li data-list-text="10."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;">TextBookofMedicinebyYashpal Munjal</p></li><li data-list-text="11."><p style="padding-top: 3pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">TextbookofPharmacovigilance:conceptandpracticebyGPMohantaandPKManna</p></li><li data-list-text="12."><p style="padding-top: 3pt;padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;"><a href="http://www.whoumc.org/DynPage.aspx?id=105825&amp;mn1=7347&amp;mn2=7259&amp;mn">http://www.whoumc.org/DynPage.aspx?id=105825&amp;mn1=7347&amp;mn2=7259&amp;mn</a></p><p style="padding-left: 64pt;text-indent: 0pt;line-height: 14pt;text-align: left;">3=7297</p></li><li data-list-text="13."><p style="padding-left: 63pt;text-indent: -17pt;text-align: left;"><a href="http://www.ich.org/">http://www.ich.org/</a></p></li><li data-list-text="14."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;"><a href="http://www.cioms.ch/">http://www.cioms.ch/</a></p></li><li data-list-text="15."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;"><a href="http://cdsco.nic.in/">http://cdsco.nic.in/</a></p></li><li data-list-text="16."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 14pt;text-align: left;"><a href="http://www.who.int/vaccine_safety/en/">http://www.who.int/vaccine_safety/en/</a></p></li><li data-list-text="17."><p style="padding-left: 63pt;text-indent: -17pt;text-align: left;"><a href="http://www.ipc.gov.in/PvPI/pv_home.html">http://www.ipc.gov.in/PvPI/pv_home.html</a></p></li></ol><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">BP806ET.QUALITYCONTROLANDSTANDARDIZATIONOFHERBALS</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">(Theory)</h3><h3 style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;line-height: 150%;text-align: justify;">Scope: <span class="p">In this subject the student learns about the various methods and guidelines forevaluation and standardization of herbs and herbal drugs. The subject also provides anopportunity forthestudenttolearncGMP,GAPandGLPintraditionalsystemofmedicines.</span></h3><h3 style="padding-top: 5pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Objectives:<span class="p">Upon completionofthesubjectstudentshallbeableto;</span></h3><ol id="l12"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 67pt;text-indent: -21pt;text-align: justify;">knowWHO guidelines forqualitycontrol ofherbal drugs</p></li><li data-list-text="2."><p style="padding-top: 5pt;padding-left: 63pt;text-indent: -17pt;text-align: justify;">knowQualityassurance in herbaldrugindustry</p></li><li data-list-text="3."><p style="padding-top: 6pt;padding-left: 64pt;text-indent: -18pt;text-align: justify;">knowtheregulatoryapprovalprocessandtheirregistrationinIndianandintern ationalmarkets</p></li><li data-list-text="4."><p style="padding-top: 6pt;padding-left: 63pt;text-indent: -17pt;text-align: justify;">appreciateEUandICH guidelinesforqualitycontrolofherbaldrugs</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitI                                      10 hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 115%;text-align: left;">Basictestsfordrugs–Pharmaceuticalsubstances,Medicinalplantsmaterialsanddosageforms WHO guidelines for quality control of herbal drugs.Evaluationofcommercialcrudedrugsintended</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">foruse</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: justify;">UnitII                                  10 hours</h3><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">Qualityassuranceinherbaldrugindustry<span class="p">ofcGMP,GAP,GMPandGLPintraditional system of medicine.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">WHOGuidelinesoncurrentgoodmanufacturingPractices(cGMP)forHerbalMedicinesWHO Guidelines onGACPforMedicinal Plants.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIII                                     10 hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">EU andICHguidelinesfor qualitycontrol ofherbal drugs. ResearchGuidelinesforEvaluatingtheSafetyand EfficacyofHerbal Medicines</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIV                                  08hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 112%;text-align: left;">Stabilitytestingofherbalmedicines.Applicationofvariouschromatographictechniquesinstand ardizationof herbal products.</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 118%;text-align: left;">PreparationofdocumentsfornewdrugapplicationandexportregistrationGMP requirementsandDrugs&amp;CosmeticsAct provisions.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitV                                      07 hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 115%;text-align: left;">Regulatoryrequirements forherbalmedicines. WHOguidelinesonsafetymonitoringofherbalmedicinesinpharmacovigilancesystemsComparisonofv arious HerbalPharmacopoeias.</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Roleofchemical andbiologicalmarkersinstandardizationofherbalproducts</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books:(LatestEditions</h3><ol id="l13"><li data-list-text="1."><p style="padding-left: 59pt;text-indent: -17pt;text-align: left;">PharmacognosybyTreaseandEvans</p></li><li data-list-text="2."><p style="padding-top: 2pt;padding-left: 59pt;text-indent: -17pt;text-align: left;">PharmacognosybyKokate,PurohitandGokhale</p></li><li data-list-text="3."><p style="padding-top: 2pt;padding-left: 59pt;text-indent: -18pt;line-height: 114%;text-align: left;">Rangari,V.D.,Text bookofPharmacognosyandPhytochemistryVol.I,CarrierPub.,2006.</p></li><li data-list-text="4."><p style="padding-left: 59pt;text-indent: -17pt;text-align: left;">Aggrawal,S.S.,HerbalDrugTechnology.UniversitiesPress,2002.</p></li><li data-list-text="5."><p style="padding-top: 1pt;padding-left: 59pt;text-indent: -18pt;line-height: 114%;text-align: left;">EMEA. Guidelines on Quality of Herbal Medicinal Products/Traditional MedicinalProducts,</p></li><li data-list-text="6."><p style="padding-left: 59pt;text-indent: -18pt;line-height: 114%;text-align: left;">Mukherjee, P.W. Quality Control of Herbal Drugs: An Approach to Evaluation ofBotanicals.BusinessHorizonsPublishers,NewDelhi,India,2002.</p></li><li data-list-text="7."><p style="padding-left: 59pt;text-indent: -18pt;line-height: 114%;text-align: left;">Shinde M.V., Dhalwal K., Potdar K., Mahadik K. Application of quality controlprinciplestoherbaldrugs.InternationalJournalofPhytomedicine1(2009);p.4- 8.</p></li><li data-list-text="8."><p style="padding-left: 59pt;text-indent: -18pt;line-height: 113%;text-align: left;">WHO. Quality Control Methods for Medicinal Plant Materials, World HealthOrganization,Geneva,1998.WHO.GuidelinesfortheAppropriateUseofHerba lMedicines. WHO Regional Publications, Western Pacific Series No 3, WHORegional officefortheWesternPacific,Manila,1998.</p></li><li data-list-text="9."><p style="padding-left: 59pt;text-indent: -18pt;line-height: 117%;text-align: left;">WHO. TheInternationalPharmacopeia,Vol. 2:QualitySpecifications, 3rdedn.WorldHealthOrganization,Geneva,1981.</p></li><li data-list-text="10."><p style="padding-left: 59pt;text-indent: -18pt;line-height: 114%;text-align: left;">WHO. Quality Control Methods for Medicinal Plant Materials. World HealthOrganization,Geneva, 1999.</p></li><li data-list-text="11."><p style="padding-left: 59pt;text-indent: -18pt;line-height: 115%;text-align: left;">WHO. WHO Global Atlas of Traditional, Complementary and AlternativeMedicine. 2 vol. set. Vol. 1 contains text and Vol. 2, maps. World HealthOrganization,Geneva, 2005.</p></li><li data-list-text="12."><p style="padding-left: 59pt;text-indent: -18pt;line-height: 117%;text-align: left;">WHO.GuidelinesonGoodAgriculturalandCollectionPractices(GACP)forMedi cinalPlants.WorldHealthOrganization,Geneva,2004.</p><h3 style="padding-top: 3pt;padding-left: 25pt;text-indent: 0pt;text-align: center;">BP807ET.COMPUTERAIDEDDRUGDESIGN(Theory)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 385pt;line-height: 115%;text-align: justify;">45HoursS cope: <span class="p">This subject is designed to provide detailed knowledge of rational drug designprocessand varioustechniques usedinrational drugdesign process.</span></h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Objectives:<span class="p">Upon completionofthecourse,thestudentshallbeabletounderstand</span></h3><ul id="l14"><li data-list-text=""><p style="padding-top: 5pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Design anddiscoveryofleadmolecules</p></li><li data-list-text=""><p style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">The role ofdrugdesignin drugdiscoveryprocess</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">TheconceptofQSAR anddocking</p></li><li data-list-text=""><p style="padding-top: 1pt;padding-left: 81pt;text-indent: -17pt;text-align: left;">Variousstrategiestodevelopnewdruglikemolecules.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 82pt;text-indent: -18pt;text-align: left;">Thedesign ofnewdrugmolecules usingmolecularmodelingsoftware</p></li></ul></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">CourseContent:</h3><h3 style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: center;">UNIT-I                                        10Hours</h3><h3 style="padding-top: 2pt;padding-left: 50pt;text-indent: 0pt;line-height: 122%;text-align: left;">IntroductiontoDrugDiscoveryandDevelopment <span class="p">Stages ofdrugdiscoveryanddevelopment </span>LeaddiscoveryandAnalogBased DrugDesign</h3><p style="padding-left: 50pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Rationalapproachestoleaddiscovery basedontraditionalmedicine,Random</p><p style="padding-left: 50pt;text-indent: 0pt;text-align: left;">screening,   Non-random   screening,   serendipitous   drug discovery,leaddiscoverybasedondrugmetabolism,leaddiscoverybasedoncli nicalobservation.</p><h3 style="padding-top: 3pt;padding-left: 50pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Analog                              BasedDrug</h3><h3 style="padding-left: 50pt;text-indent: 0pt;text-align: left;">Design:<span class="p">Bioisosterism,Classification,Bioisostericreplacement. Anythreecasestudies</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 30pt;text-indent: 0pt;text-align: center;">UNIT-II                                        10Hours</h3><h3 style="padding-top: 3pt;padding-left: 50pt;text-indent: 0pt;line-height: 108%;text-align: left;">QuantitativeStructureActivityRelationship(QSAR) <span class="p">SARversusQSAR,HistoryanddevelopmentofQSAR,Typesofphysicochemi cal  parameters,  experimental  and  theoretical  approaches  forthe</span></h3><p style="padding-left: 50pt;text-indent: 0pt;line-height: 13pt;text-align: left;">determination ofphysicochemical parameters such as Partitioncoefficient,</p><p style="padding-left: 50pt;text-indent: 0pt;text-align: left;">Hammet’ssubstituent     constant     and     Tafts    steric constant.Hanschanalysis,FreeWilsonanalysis,3D- QSARapproacheslikeCOMFAandCOMSIA.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 30pt;text-indent: 0pt;text-align: center;">UNIT-III                                       10Hours</h3><h3 style="padding-top: 3pt;padding-left: 50pt;text-indent: 0pt;line-height: 108%;text-align: left;">MolecularModelingandvirtualscreeningtechniques VirtualScreeningtechniques:<span class="p">Druglikenessscreening,Conceptofpharm acophoremappingandpharmacophorebasedScreening,</span></h3><p style="padding-top: 1pt;padding-left: 50pt;text-indent: 0pt;text-align: left;"><b>Moleculardocking</b>:Rigiddocking,flexibledocking,manualdocking,Docking based screening.<i>Denovo </i>drugdesign.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT-IV                                       08Hours</h3><h3 style="padding-top: 3pt;padding-left: 50pt;text-indent: 0pt;line-height: 106%;text-align: left;">Informatics&amp;Methodsindrugdesign <span class="p">IntroductiontoBioinformatics,chemoinformatics.ADMEdatabases,chemic al,biochemicalandpharmaceuticaldatabases.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNIT-V                                        07Hours</h3><h3 style="padding-top: 1pt;padding-left: 50pt;text-indent: 0pt;text-align: justify;">Molecular  Modeling:  <span class="p">Introduction  to  molecular  mechanics  and quantummechanics.Energy Minimization methods and Conformational Analysis,global conformational minimadetermination.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 11pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Recommended Books(LatestEditions)</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l15"><li data-list-text="1."><p style="padding-left: 63pt;text-indent: -17pt;text-align: left;">RobertGCK, ed.,“DrugAction at theMolecularLevel”UniversityPrak PressBaltimore.</p></li><li data-list-text="2."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">MartinYC.“QuantitativeDrugDesign”Dekker,NewYork.</p></li><li data-list-text="3."><p style="padding-top: 2pt;padding-left: 64pt;text-indent: -18pt;line-height: 117%;text-align: left;">DelgadoJN,RemersWAeds“Wilson&amp;Gisvolds’sTextBookofOrganicMedicinal&amp;P harmaceuticalChemistry”Lippincott,NewYork.</p></li><li data-list-text="4."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Foye WO“Principles ofMedicinalchemistry‘Lea&amp;Febiger.</p></li><li data-list-text="5."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">KorolkovasA,BurckhalterJH.“EssentialsofMedicinalChemistry”WileyInterscience</p><p style="padding-top: 2pt;padding-left: 64pt;text-indent: 0pt;text-align: left;">.</p></li><li data-list-text="6."><p style="padding-top: 2pt;padding-left: 64pt;text-indent: -18pt;line-height: 117%;text-align: left;">Wolf ME, ed “The Basis of Medicinal Chemistry, Burger’s Medicinal Chemistry”JohnWiley&amp;Sons,NewYork.</p></li><li data-list-text="7."><p style="padding-left: 63pt;text-indent: -17pt;line-height: 13pt;text-align: left;">PatrickGraham,L.,AnIntroductiontoMedicinalChemistry,OxfordUniversityPress.</p></li><li data-list-text="8."><p style="padding-top: 2pt;padding-left: 64pt;text-indent: -18pt;line-height: 114%;text-align: left;">SmithHJ,WilliamsH,eds,“IntroductiontotheprinciplesofDrugDesign”WrightBosto n.</p></li><li data-list-text="9."><p style="padding-left: 64pt;text-indent: -18pt;line-height: 117%;text-align: left;">SilvermanR.B.“TheorganicChemistryofDrugDesignandDrugAction”AcademicPre ss NewYork.</p><h3 style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 14pt;text-align: center;">BP808ET:CELLANDMOLECULARBIOLOGY(Elective subject)</h3><h3 style="text-indent: 0pt;line-height: 14pt;text-align: right;">45Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Scope:</h3><ul id="l16"><li data-list-text=""><p style="padding-left: 64pt;text-indent: -18pt;line-height: 112%;text-align: left;">Cellbiology    isabranchof    biology    thatstudies    cells    –their physiologicalproperties,theirstructure,the                 organelles theycontain,interactionswiththeirenvironment,theirlifecycle,division,deathand cellfunction.</p></li><li data-list-text=""><p style="padding-left: 63pt;text-indent: -17pt;text-align: left;">Thisisdonebothonamicroscopicandmolecularlevel.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 64pt;text-indent: -18pt;line-height: 112%;text-align: justify;">Cell           biologyresearchencompassesboththegreatdiversityofsingle- celledorganismslike     bacteria     and     protozoa,aswellasthemany specializedcellsinmulti-cellularorganismssuchas humans,plants,andsponges.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthesubjectstudentshallbeableto;</span></h3></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Summarize cellandmolecularbiologyhistory.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Summarizecellularfunctioningandcomposition.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Describethechemicalfoundationsofcellbiology.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">SummarizetheDNApropertiesofcellbiology.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Describeproteinstructureandfunction.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Describecellularmembranestructureandfunction.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Describebasicmoleculargeneticmechanisms.</p></li><li data-list-text=""><p style="padding-top: 3pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">SummarizetheCellCycle</p></li></ul></li></ol><h3 style="padding-top: 1pt;padding-left: 26pt;text-indent: 0pt;text-align: center;">Coursecontent:</h3><h3 style="padding-left: 24pt;text-indent: 0pt;text-align: center;">UnitI                                         10Hours</h3><ol id="l17"><li data-list-text="a)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CellandMolecularBiology:DefinitionstheoryandbasicsandApplications.</p></li><li data-list-text="b)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CellandMolecular Biology:HistoryandSummation.</p></li><li data-list-text="c)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Propertiesofcellsandcellmembrane.</p></li><li data-list-text="d)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">ProkaryoticversusEukaryotic</p></li><li data-list-text="e)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CellularReproduction</p></li><li data-list-text="f)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">ChemicalFoundations–anIntroductionandReactions(Types)</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 26pt;text-indent: 0pt;text-align: center;">UnitII                                         10Hours</h3><ol id="l18"><li data-list-text="a)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">DNA andtheFlowofMolecularInformation</p></li><li data-list-text="b)"><p style="padding-top: 3pt;padding-left: 66pt;text-indent: -20pt;text-align: left;">DNAFunctioning</p></li><li data-list-text="c)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">DNAandRNA</p></li><li data-list-text="d)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">TypesofRNA</p></li><li data-list-text="e)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">TranscriptionandTranslation</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 31pt;text-indent: 0pt;text-align: center;">UnitIII                                         10Hours</h3><ol id="l19"><li data-list-text="a)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Proteins: Defined<b>and</b>AminoAcids</p></li><li data-list-text="b)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">ProteinStructure</p></li><li data-list-text="c)"><p style="padding-top: 3pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">RegularitiesinProteinPathways</p></li><li data-list-text="d)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CellularProcesses</p></li><li data-list-text="e)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">PositiveControlandsignificanceofProteinSynthesis</p></li></ol><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitIV                                        08Hours</h3><ol id="l20"><li data-list-text="a)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">ScienceofGenetics</p></li><li data-list-text="b)"><p style="padding-top: 1pt;padding-left: 66pt;text-indent: -20pt;text-align: left;">TransgenicsandGenomicAnalysis</p></li><li data-list-text="c)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CellCycleanalysis</p></li><li data-list-text="d)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">MitosisandMeiosis</p></li><li data-list-text="e)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CellularActivitiesandCheckpoints</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UnitV                                         07Hours</h3><ol id="l21"><li data-list-text="a)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CellSignals:Introduction</p></li><li data-list-text="b)"><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">ReceptorsforCellSignals</p></li><li data-list-text="c)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">SignalingPathways:Overview</p></li><li data-list-text="d)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">MisregulationofSignalingPathways</p></li><li data-list-text="e)"><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Protein-Kinases:Functioning</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RecommendedBooks(latestedition):</h3><ol id="l22"><li data-list-text="1."><p style="padding-top: 1pt;padding-left: 55pt;text-indent: -18pt;line-height: 112%;text-align: left;">W.B.HugoandA.D.Russel:PharmaceuticalMicrobiology,BlackwellScientificpubl ications,OxfordLondon.</p></li><li data-list-text="2."><p style="padding-left: 55pt;text-indent: -18pt;line-height: 111%;text-align: left;">PrescottandDunn.,IndustrialMicrobiology,4<span class="s1">th</span>edition,CBSPublishers&amp;Distr ibutors,Delhi.</p></li><li data-list-text="3."><p style="padding-left: 55pt;text-indent: -17pt;text-align: left;">Pelczar,ChanKreig,Microbiology,TataMcGrawHilledn.</p></li><li data-list-text="4."><p style="padding-top: 2pt;padding-left: 55pt;text-indent: -18pt;text-align: left;">MalcolmHarris,BalliereTindallandCox:PharmaceuticalMicrobiology.</p></li><li data-list-text="5."><p style="padding-top: 2pt;padding-left: 55pt;text-indent: -18pt;text-align: left;">Rose:IndustrialMicrobiology.</p></li><li data-list-text="6."><p style="padding-top: 2pt;padding-left: 55pt;text-indent: -17pt;text-align: left;">Probisher,Hinsdilletal:FundamentalsofMicrobiology,9thed.Japan</p></li><li data-list-text="7."><p style="padding-top: 1pt;padding-left: 55pt;text-indent: -18pt;text-align: left;">CooperandGunn’s:TutorialPharmacy,CBSPublisherandDistribution.</p></li><li data-list-text="8."><p style="padding-top: 2pt;padding-left: 55pt;text-indent: -17pt;text-align: left;">Peppler:MicrobialTechnology.</p></li><li data-list-text="9."><p style="padding-top: 1pt;padding-left: 55pt;text-indent: -18pt;text-align: left;">Edward:FundamentalsofMicrobiology.</p></li><li data-list-text="10."><p style="padding-top: 2pt;padding-left: 55pt;text-indent: -18pt;text-align: left;">N.K.Jain:PharmaceuticalMicrobiology,VallabhPrakashan,Delhi</p></li><li data-list-text="11."><p style="padding-top: 1pt;padding-left: 55pt;text-indent: -18pt;line-height: 117%;text-align: left;">Bergeys manual of systematic bacteriology, Williams and Wilkins- A Waverlycompany</p></li><li data-list-text="12."><p style="padding-left: 87pt;text-indent: -50pt;line-height: 117%;text-align: left;">B.R. Glick  and  J.J.  Pasternak:  Molecular  Biotechnology:  Principles andApplicationsofRecombinantDNA: ASMPress WashingtonD.C.</p></li><li data-list-text="13."><p style="padding-left: 55pt;text-indent: -18pt;text-align: left;">RAGoldshyet.al.,:KubyImmunology.</p></li></ol><h1 style="padding-top: 3pt;padding-left: 118pt;text-indent: 0pt;text-align: left;">BP809ET.COSMETICSCIENCE<span class="s6">(Theory)</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 31pt;text-indent: 0pt;text-align: center;">45Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UNITI                                        10Hours</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 107%;text-align: left;">Classificationofcosmeticandcosmeceuticalproducts DefinitionofcosmeticsasperIndianandEUregulations,Evolutionofcosmeceuticalsfromcosm etics,cosmetics as quasiandOTC drugs</p><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 115%;text-align: left;">Cosmetic excipients: <span class="p">Surfactants, rheology modifiers, humectants, emollients,preservatives.Classification andapplication </span>Skin:<span class="p">Basicstructureandfunctionofskin.</span></h3><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Hair:<span class="p">Basicstructureofhair.Hairgrowthcycle. </span>OralCavity:<span class="p">Commonproblemassociatedwithteethandgums</span>.</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNITII                                      10Hours</h3><h3 style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Principlesof formulationandbuildingblocksofskincareproducts:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 119%;text-align: left;">Facewash, Moisturizingcream,ColdCream,Vanishingcreamandtheiradvantagesanddisadvantages.Appl ication of these products in formulation of cosmecuticals.<b>Antiperspants&amp;deodorants</b>- Actives&amp;mechanismofaction.</p><h3 style="padding-left: 28pt;text-indent: 0pt;line-height: 110%;text-align: left;">Principlesof formulationandbuildingblocksofHaircareproducts: <span class="p">Conditioningshampoo,Hairconditioner,anti- dandruffshampoo.Hairoils.</span></h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 115%;text-align: left;">Chemistry and formulation of Para-phylene diamine based hair dye.Principles of formulation and building blocks of oral care products:Toothpasteforbleedinggums,sensitiveteeth.Teethwhitening,Mouthw ash.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNITIII                                         10Hours</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Sunprotection,ClassificationofSunscreens andSPF.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Roleofherbsin cosmetics:</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: left;">Skin Care:Aloe and turmericHaircare:Hennaand amla.</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Oralcare:Neemandclove</p><h3 style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">Analyticalcosmetics:<span class="p">BIS specificationandanalyticalmethodsforshampoo,skin- creamandtoothpaste</span>.</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">UNITIV                                         08Hours<span class="p">.</span></h3><p style="padding-top: 2pt;padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">PrinciplesofCosmeticEvaluation:Principlesofsebumeter,corneometer.MeasurementofTEW L,Skin Color,Hairtensilestrength,Haircombingproperties Soaps,andsyndetbars.Evolutionandskinbenfits.</p><h3 style="padding-top: 3pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">UNITV                                      07Hours</h3><p style="padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">Oilyand dryskin,causesleadingtodryskin, skinmoisturisation.Basic understandingoftheterms Comedogenic,dermatitis.</p><p style="padding-left: 28pt;text-indent: 0pt;line-height: 113%;text-align: left;">Cosmetic problems associated with Hair and scalp: Dandruff, Hair fall causesCosmeticproblemsassociatedwithskin:blemishes,wrinkles,acne,pricklyheatandb odyodor.</p><p style="padding-left: 28pt;text-indent: 0pt;text-align: left;">AntiperspirantsandDeodorants-Activesandmechanismofaction</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">References</h3><ol id="l23"><li data-list-text="1)"><p style="padding-top: 1pt;padding-left: 55pt;text-indent: -17pt;text-align: left;">Harry’sCosmeticology,Wilkinson,Moore,SeventhEdition,George Godwin.</p></li><li data-list-text="2)"><p style="padding-top: 2pt;padding-left: 55pt;text-indent: -18pt;line-height: 118%;text-align: left;">Cosmetics– Formulations,ManufacturingandQualityControl,P.P.Sharma,4<span class="s1">th</span>Edition,VandanaPub lications Pvt.Ltd., Delhi.</p></li><li data-list-text="3)"><p style="padding-left: 55pt;text-indent: -16pt;line-height: 13pt;text-align: left;">Text bookof cosmelicologybySanju Nanda&amp;RoopK. Khar, TataPublishers.</p><h3 style="padding-top: 3pt;padding-left: 112pt;text-indent: 0pt;line-height: 127%;text-align: left;">BP810ET.EXPERIMENTAL PHARMACOLOGY (PHARMACOLOGICALSCREENINGMETHODS)</h3><h3 style="padding-top: 8pt;text-indent: 0pt;text-align: right;">45Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;line-height: 117%;text-align: left;">Scope:<span class="p">Thissubjectisdesignedtoimpartthebasicknowledgeofpreclinicalstudiesinexperimentalanimals includingdesign,conductandinterpretationsofresults.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives</h3><p style="padding-top: 1pt;padding-left: 28pt;text-indent: 0pt;text-align: left;">Uponcompletionofthecoursethestudentshallbeableto,</p><ul id="l24"><li data-list-text=""><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">Appreciatetheapplications ofvarious commonlyusedlaboratoryanimals.</p></li><li data-list-text=""><p style="padding-top: 2pt;padding-left: 62pt;text-indent: -16pt;text-align: left;">Appreciate<span class="s7">anddemonstrate</span></p><p style="padding-left: 210pt;text-indent: 0pt;line-height: 13pt;text-align: left;">thevariousscreeningmethodsusedin<span class="s7">preclinicalresearc</span></p><p class="s8" style="padding-left: 63pt;text-indent: 0pt;line-height: 13pt;text-align: left;">h</p></li><li data-list-text=""><p style="padding-left: 63pt;text-indent: -17pt;line-height: 15pt;text-align: left;">Appreciate<span class="s7">anddemonstratetheimportanceofbiostatisticsandresearch</span>methodology</p></li><li data-list-text=""><p style="padding-left: 63pt;text-indent: -17pt;line-height: 15pt;text-align: left;">Designandexecutearesearch hypothesisindependently</p></li></ul></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:22.01pt" cellspacing="0"><tr style="height:16pt"><td style="width:380pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Unit–I</p></td><td style="width:71pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">08Hours</p></td></tr><tr style="height:127pt"><td style="width:380pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">LaboratoryAnimals:</p><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">Study of CPCSEA and OECD guidelines for maintenance, breedingandconductofexperimentsonlaboratoryanimals,Commonlabanimals: Descriptionandapplicationsofdifferentspeciesandstrainsofanimals. Popular transgenicandmutant animals.</p><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: left;">Techniquesforcollectionofbloodandcommonroutesofdrugadministration in laboratory animals,Techniquesof blood collectionandeuthanasia.</p></td><td style="width:71pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:24pt"><td style="width:380pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit–II</p></td><td style="width:71pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">10Hours</p></td></tr><tr style="height:218pt"><td style="width:380pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Preclinicalscreening models</p><ol id="l25"><li data-list-text="a."><p class="s10" style="padding-left: 25pt;text-indent: -18pt;line-height: 114%;text-align: left;">Introduction:  Dose selection, calculation and conversions,preparation of drug solution/suspensions, grouping of animals andimportanceofshamnegativeandpositivecontrolgroups.Rationaleforsele ctionof animalspeciesandsexforthestudy.</p></li><li data-list-text="b."><p class="s9" style="padding-left: 25pt;text-indent: -18pt;text-align: left;">Studyof screeninganimalmodelsfor</p></li></ol><p class="s10" style="padding-top: 1pt;padding-left: 5pt;padding-right: 49pt;text-indent: 19pt;line-height: 114%;text-align: left;">Diuretics, nootropics, anti- Parkinson’s,antiasthmatics,<b>Preclinical screening models: </b>for CNS activity- analgesic,antipyretic,anti- inflammatory,generalanaesthetics,sedativeandhypnotics, antipsychotic, antidepressant, antiepileptic,antiparkinsonism,alzheimer’s disease</p></td><td style="width:71pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr></table><table style="border-collapse:collapse;margin-left:22.01pt" cellspacing="0"><tr style="height:92pt"><td style="width:380pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit–III</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s9" style="padding-left: 5pt;padding-right: 13pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Preclinical screening models: <span class="s10">for ANS activity, sympathomimetics,sympatholytics, parasympathomimetics, parasympatholytics,</span></p><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">skeletalmusclerelaxants,drugsactingoneye,localanaethetics</p></td><td style="width:71pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="text-indent: 0pt;line-height: 14pt;text-align: left;">10Hours</p></td></tr><tr style="height:120pt"><td style="width:380pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Unit–IV</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s9" style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">Preclinicalscreeningmodels:<span class="s10">forCVSactivity-antihypertensives,diuretics, antiarrhythmic, antidyslepidemic, anti aggregatory,coagulants, and anticoagulants</span></p><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: left;">Preclinicalscreeningmodelsforotherimportantdrugslike antiulcer,antidiabetic,anticancerand antiasthmatics.</p></td><td style="width:71pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="text-indent: 0pt;line-height: 14pt;text-align: left;">10Hours</p></td></tr><tr style="height:80pt"><td style="width:380pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="padding-left: 18pt;text-indent: -13pt;line-height: 110%;text-align: left;">ResearchmethodologyandBio-statistics <span class="s10">Selectionofresearchtopic,reviewofliterature,researchhypothesisandstudyde sign</span></p><p class="s10" style="padding-left: 18pt;padding-right: 58pt;text-indent: 0pt;line-height: 114%;text-align: left;">Pre-clinicaldataanalysisandinterpretationusingStudents‘t’test and One-wayANOVA.Graphicalrepresentationof data</p></td><td style="width:71pt;border-top-style:solid;border-top-width:1pt;border-left-style:solid;border-left-width:1pt;border-bottom-style:solid;border-bottom-width:1pt;border-right-style:solid;border-right-width:1pt"><p class="s9" style="text-indent: 0pt;line-height: 14pt;text-align: left;">05Hours</p></td></tr></table><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RecommendedBooks(latestedition):</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l26"><li data-list-text="1."><p style="padding-left: 63pt;text-indent: -17pt;text-align: left;">FundamentalsofexperimentalPharmacology-byM.N.Ghosh</p></li><li data-list-text="2."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">HandbookofExperimentalPharmacology-S.K.Kulakarni</p></li><li data-list-text="3."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">CPCSEAguidelinesforlaboratoryanimalfacility.</p></li><li data-list-text="4."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">DrugdiscoveryandEvaluationbyVogelH.G.</p></li><li data-list-text="5."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">DrugScreeningMethodsbySureshKumar GuptaandS. K. Gupta</p></li><li data-list-text="6."><p style="padding-top: 2pt;padding-left: 64pt;text-indent: -18pt;text-align: left;">IntroductiontobiostatisticsandresearchmethodsbyPSSSundarRaoandJRichard</p><h3 style="padding-top: 3pt;padding-left: 25pt;text-indent: 0pt;text-align: center;">BP811ET. ADVANCEDINSTRUMENTATIONTECHNIQUES</h3><h3 style="padding-top: 2pt;text-indent: 0pt;text-align: right;">45Hours</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;line-height: 114%;text-align: left;">Scope: <span class="p">This subject deals with the application of instrumental methods in qualitative andquantitative analysis of drugs. This subject is designed to impart advanced knowledge ontheprinciplesandinstrumentationofspectroscopicandchromatographichyphenatedtechniq ues.Thisalsoemphasizesontheoreticalandpracticalknowledgeonmodernanalyticalinstrument s that areusedfordrugtesting.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">Objectives:<span class="p">Upon completionofthecoursethestudentshallbeableto</span></h3><ul id="l27"><li data-list-text=""><p style="padding-top: 2pt;padding-left: 64pt;text-indent: -17pt;text-align: left;">understandtheadvancedinstrumentsusedanditsapplicationsindruganalysis</p></li><li data-list-text=""><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">understandthechromatographicseparationandanalysisofdrugs.</p></li><li data-list-text=""><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">understandthecalibrationofvariousanalyticalinstruments</p></li><li data-list-text=""><p style="padding-top: 1pt;padding-left: 63pt;text-indent: -17pt;text-align: left;">knowanalysisof drugsusingvariousanalyticalinstruments.</p></li></ul></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-top: 12pt;padding-left: 25pt;text-indent: 0pt;text-align: center;">CourseContent:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-I                                        10Hours</h3><h3 style="padding-top: 2pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">NuclearMagneticResonancespectroscopy</h3><p style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;line-height: 114%;text-align: justify;">Principles  of  H-NMR  and  C-NMR,  chemical  shift,  factors  affecting chemicalshift,  coupling  constant,  Spin  -  spin  coupling,  relaxation, instrumentation andapplications</p><h3 style="padding-left: 23pt;text-indent: 0pt;line-height: 112%;text-align: left;">MassSpectrometry<span class="p">-Principles,Fragmentation,Ionizationtechniques– Electronimpact,chemicalionization,MALDI,FAB,Analyzers- TimeofflightandQuadrupole,instrumentation, applications</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-II                                        10Hours</h3><h3 style="padding-top: 1pt;padding-left: 25pt;text-indent: -1pt;line-height: 113%;text-align: justify;">ThermalMethods ofAnalysis<span class="p">: Principles, instrumentationand applicationsof ThermogravimetricAnalysis  (TGA),  Differential  Thermal  Analysis (DTA),Differential ScanningCalorimetry(DSC)</span></h3><ol id="l28"><li data-list-text="X-"><h3 style="padding-left: 59pt;text-indent: -36pt;line-height: 117%;text-align: justify;">Ray Diffraction Methods: <span class="p">Origin of X-rays, basic aspects of crystals, X- ray</span></h3><p style="padding-left: 23pt;text-indent: 3pt;line-height: 111%;text-align: justify;">Crystallography,   rotating   crystal   technique,   single   crystal diffraction,powderdiffraction,structural elucidationandapplications.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-III                                       10Hours</h3><h3 style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;line-height: 122%;text-align: left;">Calibrationandvalidation-<span class="p">asperICHandUSFDAguidelines </span>CalibrationoffollowingInstruments</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 23pt;text-indent: 0pt;text-align: left;">Electronicbalance,UV-Visiblespectrophotometer,IRspectrophotometer,</p><p style="padding-top: 3pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">Fluorimeter,FlamePhotometer,HPLCandGC</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-IV                                       08Hours</h3><h3 style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;line-height: 113%;text-align: left;">Radio immune assay:<span class="p">Importance, various components, Principle, differentmethods,Limitation andApplicationsofRadioimmuno assay </span>Extractiontechniques<span class="p">:Generalprincipleandprocedureinvolvedinthesolidphaseextr action andliquid-liquidextraction</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 23pt;text-indent: 0pt;text-align: left;">UNIT-V                                        07Hours</h3><h3 style="padding-top: 1pt;padding-left: 23pt;text-indent: 0pt;text-align: left;">Hyphenatedtechniques<span class="p">-LC-MS/MS,GC-MS/MS,HPTLC-MS.</span></h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 28pt;text-indent: 0pt;text-align: left;">RecommendedBooks(LatestEditions)</h3><ol id="l29"><li data-list-text="1."><p style="padding-top: 1pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">InstrumentalMethodsofChemicalAnalysis byB.KSharma</p></li><li data-list-text="2."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">Organic spectroscopybyY.RSharma</p></li><li data-list-text="3."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">TextbookofPharmaceutical Analysis byKennethA.Connors</p></li><li data-list-text="4."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">Vogel’sTextbookofQuantitativeChemicalAnalysisbyA.I.Vogel</p></li><li data-list-text="5."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">Practical PharmaceuticalChemistrybyA.H.BeckettandJ.B.Stenlake</p></li><li data-list-text="6."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">OrganicChemistrybyI.L.Finar</p></li><li data-list-text="7."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">Organic spectroscopybyWilliamKemp</p></li><li data-list-text="8."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">QuantitativeAnalysisofDrugsbyD.C.Garrett</p></li><li data-list-text="9."><p style="padding-top: 2pt;padding-left: 50pt;text-indent: -13pt;text-align: left;">Quantitative Analysisof Drugs in PharmaceuticalFormulationsbyP.D. Sethi</p></li><li data-list-text="10."><p style="padding-top: 2pt;padding-left: 63pt;text-indent: -26pt;text-align: left;">Spectrophotometric identification of OrganicCompoundsbySilverstein</p></li></ol></li></ol><h3 style="padding-top: 3pt;padding-left: 25pt;text-indent: 0pt;text-align: center;">BP812ET.DIETARYSUPPLEMENTSANDNUTRACEUTICALS</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;line-height: 188%;text-align: left;">No.ofhours:3                  Tutorial:1           Credit point:4Scope:</h3><p style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">Thissubjectcoversfoundationaltopicthatareimportantforunderstandingtheneedandrequirementso fdietarysupplementsamongdifferent groupsinthepopulation.</p><h3 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Objective:</h3><p style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">This module aims to provide an understanding of the concepts behind the theoreticalapplicationsofdietarysupplements.Bytheendofthecourse,studentsshouldbe ableto:</p><ol id="l30"><li data-list-text="1."><p style="padding-top: 10pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	Understandtheneedofsupplementsbythedifferentgroupofpeopletomaintainhealthy life.</p></li><li data-list-text="2."><p style="padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">Understandtheoutcomeofdeficienciesindietarysupplements.</p></li><li data-list-text="3."><p style="padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">Appreciatethecomponentsindietarysupplementsandtheapplication.</p></li><li data-list-text="4."><p style="padding-left: 41pt;text-indent: -18pt;text-align: left;">	Appreciatetheregulatoryand commercialaspectsofdietarysupplementsincludinghealthclaims.</p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNITI                                          07 hours</h3><ol id="l31"><li data-list-text="a."><p style="padding-top: 11pt;padding-left: 41pt;text-indent: -18pt;line-height: 114%;text-align: justify;">	Definitions  of  Functional  foods,  Nutraceuticals  and  Dietary  supplements. Classificationof Nutraceuticals, Health problems and diseases that can be prevented or cured byNutraceuticals i.e. weight control, diabetes, cancer, heart disease, stress, osteoarthritis,hypertensionetc.</p></li><li data-list-text="b."><p style="padding-left: 41pt;text-indent: -18pt;line-height: 112%;text-align: justify;">	Public  health  nutrition,  maternal  and  child  nutrition,  nutrition  and  ageing, nutritioneducationincommunity.</p></li><li data-list-text="c."><p style="padding-left: 41pt;text-indent: -18pt;line-height: 115%;text-align: left;">	Source, Name of marker compounds and their chemical nature, Medicinal uses andhealthbenefitsoffollowingusedasnutraceuticals/functionalfoods:Spirulina,Soyabean, Ginseng, Garlic, Broccoli,Gingko,Flaxseeds</p></li></ol></li></ol><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNITII                                         15 hours</h3><p style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">Phytochemicalsasnutraceuticals:Occurrenceandcharacteristicfeatures(chemicalnaturemedicinal benefits)offollowing</p><ol id="l32"><li data-list-text="a)"><p style="padding-top: 9pt;padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">Carotenoids-αandβ-Carotene,Lycopene,Xanthophylls,leutin</p></li><li data-list-text="b)"><p style="padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">Sulfides:Diallylsulfides,Allyltrisulfide.</p></li><li data-list-text="c)"><p style="padding-left: 42pt;text-indent: -18pt;text-align: left;">Polyphenolics:Reservetrol</p></li><li data-list-text="d)"><p style="padding-top: 2pt;padding-left: 42pt;text-indent: -18pt;text-align: left;">Flavonoids-Rutin,Naringin,Quercitin,Anthocyanidins,catechins,Flavones</p></li><li data-list-text="e)"><p style="padding-top: 1pt;padding-left: 42pt;text-indent: -18pt;text-align: left;">Prebiotics/Probiotics.:Fructooligosaccharides,Lactobacillum</p></li><li data-list-text="f)"><p style="padding-top: 1pt;padding-left: 42pt;text-indent: -18pt;text-align: left;">Phytoestrogens:Isoflavones,daidzein,Geebustin,lignans</p></li><li data-list-text="g)"><p style="padding-left: 41pt;text-indent: -17pt;text-align: left;">Tocopherols</p></li><li data-list-text="h)"><p style="padding-left: 41pt;text-indent: -18pt;text-align: left;">	Proteins,vitamins, minerals,cereal, vegetablesandbeveragesasfunctionalfoods: oats,wheatbran,ricebran, sea foods, coffee,teaandthelike.</p></li></ol><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNITIII                                         07 hours</h3><ol id="l33"><li data-list-text="a)"><p style="padding-top: 11pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	Introduction to free radicals: Free radicals, reactive oxygen species, production of freeradicalsincells,damagingreactionsoffreeradicalsonlipids,proteins,Carbohydrates,nu cleicacids.</p></li><li data-list-text="b)"><p style="padding-top: 3pt;padding-left: 42pt;text-indent: -18pt;text-align: left;">Dietaryfibresandcomplexcarbohydrates asfunctionalfoodingredients..</p></li></ol><h3 style="padding-left: 9pt;text-indent: 0pt;text-align: left;">UNITIV                                        10 hours</h3><ol id="l34"><li data-list-text="a)"><p style="padding-top: 11pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	FreeradicalsinDiabetesmellitus, Inflammation, Ischemicreperfusioninjury,Cancer,Atherosclerosis, Free radicals in brain metabolism and pathology, kidney damage,muscle damage. Free radicals involvement in other disorders. Free radicals theory ofageing.</p></li><li data-list-text="b)"><p style="padding-left: 41pt;text-indent: -18pt;text-align: left;">	Antioxidants:  Endogenous  antioxidants  –  enzymatic  and  nonenzymatic antioxidantdefence,Superoxidedismutase,catalase,Glutathioneperoxidase,GlutathioneV itaminC,VitaminE,α-Lipoicacid,melatonin Syntheticantioxidants:ButylatedhydroxyToluene,ButylatedhydroxyAnisole.</p></li><li data-list-text="c)"><p style="padding-left: 45pt;text-indent: -21pt;line-height: 14pt;text-align: left;">Functionalfoodsforchronicdiseaseprevention</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 9pt;text-indent: 0pt;text-align: left;">UNITV                                         06 hours</h3><ol id="l35"><li data-list-text="a)"><p style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: left;">Effectofprocessing,storageandinteractionsofvariousenvironmentalfactorsonthepotentialofnut raceuticals.</p></li><li data-list-text="b)"><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">RegulatoryAspects;FSSAI,FDA,FPO,MPO,AGMARK.HACCPandGMPsonFoodSafety.Ad ulterationoffoods.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="c)"><p style="padding-left: 18pt;text-indent: -12pt;text-align: left;">PharmacopoeialSpecificationsfordietarysupplementsandnutraceuticals.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">References:</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l36"><li data-list-text="1."><p style="padding-left: 42pt;text-indent: -18pt;text-align: left;">DieteticsbySriLakshmi</p></li><li data-list-text="2."><p style="padding-left: 41pt;text-indent: -18pt;text-align: left;">	RoleofdietaryfibresandneutraceuticalsinpreventingdiseasesbyK.TAgustiandP.Faizal:BS Punblication.</p></li><li data-list-text="3."><p style="padding-left: 42pt;text-indent: -18pt;text-align: left;">Advanced NutritionalTherapiesbyCooper.K.A., (1996).</p></li><li data-list-text="4."><p style="padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">TheFoodPharmacybyJeanCarper,Simon&amp;Schuster,UKLtd.,(1988).</p></li><li data-list-text="5."><p style="padding-left: 41pt;text-indent: -18pt;text-align: left;">	PrescriptionforNutritionalHealingbyJamesF.BalchandPhyllisA.Balch2<span class="s1">nd</span>Edn.,AveryPubl ishingGroup,NY(1997).</p></li><li data-list-text="6."><p style="padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">G.GibsonandC.williamsEditors <i>2000Functionalfoods</i>WoodheadPubl.Co.London.</p></li><li data-list-text="7."><p style="padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">Goldberg,I.<i>FunctionalFoods</i>.1994.ChapmanandHall,New York.</p></li><li data-list-text="8."><p style="padding-left: 41pt;text-indent: -18pt;text-align: left;">	Labuza,T.P.2000FunctionalFoodsandDietarySupplements:Safety,GoodManufacturing Practice(GMPs)  and  Shelf  Life  Testing  in<i>Essentials  of  FunctionalFoods </i>M.K.Sachmidland T.P.Labuzaeds.AspenPress.</p></li><li data-list-text="9."><p class="s11" style="padding-left: 42pt;text-indent: -18pt;line-height: 14pt;text-align: left;">HandbookofNutraceuticalsandFunctionalFoods,ThirdEdition(ModernNutrition)</p></li><li data-list-text="10."><p style="padding-top: 4pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	Shils,  ME,  Olson,  JA,  Shike,  M.  1994  <i>Modern  Nutrition  in  Health  and Disease</i>.Eighthedition.LeaandFebiger</p><h3 style="padding-top: 3pt;padding-left: 13pt;text-indent: 0pt;line-height: 148%;text-align: left;">SemesterVIII–Elective course on PharmaceuticalProductDevelopmentNoofHours:3 Tutorial:1</h3><h3 style="padding-left: 154pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Creditpoints:4</h3><h3 style="padding-top: 7pt;padding-left: 6pt;text-indent: 0pt;text-align: justify;">Unit-I                                         10Hours</h3><p style="padding-top: 1pt;padding-left: 17pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Introduction to pharmaceutical product development, objectives, regulations related topreformulation,formulationdevelopment,stabilityassessment,manufacturingandqual itycontroltestingofdifferent types ofdosageforms</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 17pt;text-indent: 0pt;text-align: left;">Unit-II                                         10Hours</h3><p style="padding-top: 1pt;padding-left: 17pt;text-indent: 0pt;line-height: 112%;text-align: left;">Anadvancedstudy ofPharmaceuticalExcipientsinpharmaceuticalproductdevelopmentwithaspecialreferenceto thefollowingcategories</p><ol id="l37"><li data-list-text="i."><p style="padding-left: 89pt;text-indent: -35pt;text-align: left;">Solventsandsolubilizers</p></li><li data-list-text="ii."><p style="padding-top: 2pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Cyclodextrinsandtheirapplications</p></li><li data-list-text="iii."><p style="padding-top: 1pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Non-ionicsurfactantsandtheirapplications</p></li><li data-list-text="iv."><p style="padding-top: 2pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Polyethyleneglycolsandsorbitols</p></li><li data-list-text="v."><p style="padding-top: 2pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Suspendingandemulsifyingagents</p></li><li data-list-text="vi."><p style="padding-top: 1pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Semisolidexcipients</p></li></ol></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 17pt;text-indent: 0pt;text-align: left;">Unit-III                                          10Hours</h3><p style="padding-top: 1pt;padding-left: 17pt;text-indent: 0pt;line-height: 111%;text-align: left;">AnadvancedstudyofPharmaceuticalExcipientsinpharmaceuticalproductdevelopmentw ithaspecial referencetothefollowingcategories</p><ol id="l38"><li data-list-text="i."><p style="padding-left: 89pt;text-indent: -35pt;text-align: left;">Tabletandcapsuleexcipients</p></li><li data-list-text="ii."><p style="padding-top: 2pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Directlycompressiblevehicles</p></li><li data-list-text="iii."><p style="padding-top: 2pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Coatmaterials</p></li><li data-list-text="iv."><p style="padding-top: 2pt;padding-left: 89pt;text-indent: -35pt;text-align: left;">Excipientsinparenteralandaerosolsproducts</p></li><li data-list-text="v."><p style="padding-top: 1pt;padding-left: 17pt;text-indent: 36pt;line-height: 117%;text-align: left;">ExcipientsforformulationofNDDS Selectionandapplicationofexcipientsinpharmaceuticalformulationswithspecificindustr ialapplications</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 17pt;text-indent: 0pt;text-align: left;">Unit-IV                                          08Hours</h3><p style="padding-top: 1pt;padding-left: 17pt;text-indent: 0pt;line-height: 113%;text-align: left;">Optimizationtechniquesinpharmaceuticalproductdevelopment.Astudy ofvariousoptimizationtechniquesforpharmaceuticalproductdevelopmentwithspecifice xamples.Optimization by factorial designs and their applications.A study of QbD and itsapplicationinpharmaceutical productdevelopment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h3 style="padding-left: 17pt;text-indent: 0pt;text-align: left;">Unit-V                                          07Hours</h3><p style="padding-top: 1pt;padding-left: 17pt;text-indent: 0pt;line-height: 114%;text-align: left;">Selectionandqualitycontroltestingofpackagingmaterialsforpharmaceuticalproductdev elopment-regulatoryconsiderations.</p></body></html>
